News

White Wine and Liquor Consumption May Increase Risk of Rosacea

White wine consumption may increase risk of rosacea

New research published online on April 20, 2017 in the Journal of the American Academy of Dermatology revealed that increased consumption of alcohol, particularly white wine and liquor, is associated with a higher risk of rosacea in women.

To examine rosacea’s connection to alcohol use in women, the authors—led by Wen-Qing Li, an assistant professor of dermatology at Brown University—reviewed data collected from 82,737 women over 14 years (1991-2005) via the Nurses’ Health Study II. There were 4,945 cases on rosacea.

Rosacea Awareness Month: How To Take Part

April is Rosacea Awareness Month

April is Rosacea Awareness Month, and the National Rosacea Society (NRS) is encouraging physicians and patients to take part in educating the public on this chronic and widespread facial disorder now estimated to affect more than 16 million Americans.

The NRS designated April Rosacea Awareness Month 25 years ago in an effort to encourage more people who may have rosacea to seek medical help before it gets worse, and to help those affected find greater public acceptance and understanding.

ASLMS Award Winners

Young Investigator Award Winner, Bo Chen, PhD

The American Society for Laser Medicine & Surgery (ASLMS) presented six honorary awards to individuals who have made significant contributions to the field of laser and energy-based medical devices. The awards were presented during the ASLMS Annual Conference in San Diego in April and included:

Results From Phase 4 Clinical Studies of Restylane Refyne and Restylane Defyne Released

Phase 4 Clinical Study Results on Restylane Refyne and Defyne

Galderma has released the results from two Phase 4 clinical studies of Restylane Refyne and Restylane Defyne, the most recent U.S. additions to it Restylane family of soft tissue fillers. The Natural Expression study found that natural facial expression was maintained in 95% (60/63) of subjects (primary objective). The Dynamic Strain study found that 83% (25/30) of subjects had enhanced attractiveness, looked younger and maintained expression following injections of Restylane Refyne and Restylane Defyne.

Apax Partners to Acquire Syneron

Syneron Candela

Aesthetic device manufacturer Syneron Medical has entered into an agreement with Apax Partners, a global private equity advisory firm, under which an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of Syneron-Candela for $11.00 per share in cash in a transaction valued at approximately $397 million.

American Skin Association Honors Three at 30-Year Celebration

On Monday, March 27, the American Skin Association (ASA) celebrated its 30 years anniversary by presenting awards to three honorees who have made a significant impact in the areas of skin health and research. The ASA and its affiliates have funded more than $50 million in grants to support the work of more than 300 promising young scientists. In addition, the organization works to educate the public on skin health through its ASA Education Council. Monday night's honorees included: